NOVEL ENOL-ACETATES(II)

Information

  • Patent Application
  • 20220220071
  • Publication Number
    20220220071
  • Date Filed
    April 03, 2020
    4 years ago
  • Date Published
    July 14, 2022
    2 years ago
Abstract
The present invention relates to new specific enol esters of formula (I) as well as to a process for their production by acylation of the corresponding dihydroretinal analogue. In formula (I) R is —COR′ where R′ is a C1-C16 alkyl group.
Description
NOVEL ENOL-ACETATES(II)

The present invention relates to new specific enol acetates as well as to their production.


Enol acetates are important intermediates in various organic syntheses.


The new enol acetates we have found are those of formula (I)




embedded image


wherein


R is —COR′, wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


There are two isomers (compound of formula (Ia) and (Ib))




embedded image


wherein

    • R is —COR′, wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15 alkyl group).


Therefore, the present invention relates to compounds of formula (I)




embedded image


wherein

    • R is —COR′, wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


Therefore, the present invention relates to the compounds of formula (Ia)




embedded image


wherein

    • R is —COR′, wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


Therefore, the present invention related to the compounds of formula (Ib)




embedded image


wherein

    • R is —COR′, wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


Due to the C-C-double bonds, there is variety of stereoisomeric forms.


These new enol acetates are important and useful intermediates in organic syntheses (especially in the synthesis of vitamin A and/or its derivatives). The enol acetate according to the present invention are produced by an enol-acetate formation of the compound of formula (II)




embedded image


Compound of formula (II) has two isomers (among others) of the following formula (IIa) and (IIb):




embedded image


The process is carried out in the presence of at least one acetylating agent, which is a compound of formula (III)




embedded image


wherein




embedded image


R is —COR′ or wherein R′ is a C1-C16 alkyl group (preferably a C2 or C15-alkyl group)


R″ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


Alternatively, the process of the present invention can be carried out in the presence of a transition metal catalyst. Especially in the presence of a Cu catalyst. Especially a Cu(II) catalyst. Very suitable is Cu(Ac)2 as a catalyst.


Therefore, the present invention relates to a process (P) for the production of the compounds of formula (I)




embedded image


wherein

    • R is —COR', wherein R′ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group)


by acetylation of a compound of formula (II)




embedded image


by using at least one acetylating agent of formula (III)




embedded image


wherein




embedded image


R is —COR′ or wherein R′ is a C1-C16 alkyl group (preferably a C2 or C15-alkyl group)


R″ is a C1-C16 alkyl group (preferably a C1, C2 or C15-alkyl group).


Alternatively (optionally), the process according to the present invention can be carried out in the presence of at least one transition metal catalyst; especially in the presence of a Cu catalyst. Especially a Cu(II) catalyst. Very suitable is Cu(Ac)2 as a catalyst.


The amount of the catalyst used in the process according to the present invention can vary. The amount of the catalyst usually goes from 0.001 mol-equivalent up to 0.01 mol-equivalent (in relation to compound of formula (II)).


The process according to the present invention is usually carried out in the presence of at least one organic acid or in the presence of a base. Especially in the presence of p-toluenesulfonic acid.


The amount of the acid or of the base can vary. It goes usually from 0.005 mol-equivalent up to 0.1 mol-equivalent (in relation to compound of formula (II)).


The reaction is can be carried out in an inert solvent or the reaction can be carried out without a solvent. Preferably no solvent is used.


The process according to the present is usually carried out at elevated temperatures. Usually the process according to the present invention is carried out at a temperature of from 0° C. 100° C., preferably from 5° C. 90° C.


As stated above the process according to the present invention is one important step in the synthesis of vitamin A (and/or its derivatives).


The following examples serve to illustrate the invention. The temperature is given in ° C. and all percentages are related to the weight.







Examples
Example 1:

A flame-dried 2-necked flask equipped with a reflux condenser was charged with p-toulenesulfonic acid (dry, 0.01 eq), hydroquinone (0.01 eq), copper(I1)acetate (0.004 eq), isopropenylacetate (2.0 eq) and 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6-trienal (1.0 eq) in the given order. The reaction mixture was stirred for 3 h at 60 ° C., cooled to room temperature and Et2O (10 mL) was added. The solution was washed with aqueous sat. NaHCO3-solution (5 mL). The aqueous phase was extracted with Et2O (5 mL) and the combined organic layers were concentrated under reduced pressure (45° C., 2 mbar). The crude material was filtered over silica (first washed with heptane, then with ethylacetate) to afford the product as mixture of isomers.

Claims
  • 1. Compounds of formula (I)
  • 2. Compounds according to claim 1, which has formula (Ia)
  • 3. Compound according to claim 1, which has formula (Ib)
  • 4. Process for the production of the compounds of formula (I) according to claim 1
  • 5. Process according to claim 4, wherein the process is carried out in the presence of at least one transition metal catalyst.
  • 6. Process according to claim 4, wherein the amount of the catalyst is 0.001 mol-equivalent up to 0.01 mol-equivalent (in relation to compound of formula (II)).
  • 7. Process according to claim 4, wherein the process is carried out in the presence of at least one organic acid.
  • 8. Process according to claim 4, wherein the process is carried out in the presence of at least one base.
  • 9. Process according to claim 7, wherein the amount of the acid or base is 0.005 mol-equivalent up to 0.1 mol-equivalent (in relation to compound of formula (II)).
  • 10. Process according to claim 4, wherein the process is carried out in an inert solvent.
  • 11. Process according to claim 4, wherein the process is carried out without any solvent.
  • 12. Process according to claim 4, wherein the process is carried out at a temperature of from 0° C. 100° C. (preferably from 5° C. 90° C.).
Priority Claims (1)
Number Date Country Kind
19169208.6 Apr 2019 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2020/059482 4/3/2020 WO 00